Cytomegalovirus Retinitis Market - Global
Industry Analysis, Size, Share, Growth, Trends, Single User
and Forecast 2015 - 2023
USD 4315.5
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
License:
Flat 10% Discount!!
Free Customization as per your requirement
You will get Custom Report at Syndicated Report
price
Report will be delivered with in 15-20 working days
Request Sample
Buy Now
REPORT DESCRIPTION
Cytomegalovirus (CMV) Retinitis is caused by cytomegalovirus infection, which is a herpes-type virus that affects the retina of the human eye
among patients having a weak immune system that could be due to conditions such as AIDS, leukemia and/or pregnancy. Symptomatic conditions
include floaters, flashes, and blind spots besides loss of peripheral or blurred vision in the eyes of immune compromised patients.CMV infection
often leads to hemorrhagic retinal inflammation along with vascular distribution. The CMV infection if left untreated spreads from one eye to the
other, eventually leading to visual loss and/or complete blindness. Therefore, prompt diagnosis through blood as well as urine tests besides other
optical tests that involve withdrawal of a small specimen fluid from the infected eye is recommended.
Browse Full Report With TOC:- http://www.transparencymarketresearch.com/cytomegalovirus-retinitis-market.html
Global CMV retinitis market can be segmented on the basis of anti-CMV drugs or anti-infective ophthalmic drugs into Foscarnet, Ganciclovir,
Cidofovir, Fomivirsen and others. In the anti-CMV drugs segment, various off-label drugs are also being used, however many of these drugs have
serious contraindications. In this market segment, one of the key challenges is drug resistance which needs to be counterfeited with clinical trials
and pipeline drugs. For instance,...